红细胞增多症-话题@MedSci

#红细胞增多症#

26篇内容 | 1575人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1555476, encodeId=149015554e673, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Leukemia Res：阿那格雷在真性红细胞增多症中用于血小板定向细胞减少：从大型多中心数据库中洞察实用性和安全性结果, objectType=article, longId=738953, objectId=27eee3895398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27eee3895398, replyNumber=0, likeNumber=95, createdTime=2022-09-12, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27eee3895398, moduleTitle=Leukemia Res：阿那格雷在真性红细胞增多症中用于血小板定向细胞减少：从大型多中心数据库中洞察实用性和安全性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27eee3895398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555475, encodeId=c3fb15554e58a, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=KIDNEY INT：有“高原红细胞增多症”的藏族居民，他们的肾脏临床病理特征表现如何？, objectType=article, longId=730347, objectId=ba18e30347d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba18e30347d9, replyNumber=0, likeNumber=77, createdTime=2022-06-25, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba18e30347d9, moduleTitle=KIDNEY INT：有“高原红细胞增多症”的藏族居民，他们的肾脏临床病理特征表现如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba18e30347d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555474, encodeId=c76d15554e403, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=AOP Health在2022年欧洲血液学协会年会上公布CONTINUATION-PV研究的最终结果——BESREMi®（罗培根干扰素α-2b）治疗真性红细胞增多症患者长达7.5年, objectType=article, longId=730162, objectId=903de30162e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=903de30162e2, replyNumber=0, likeNumber=78, createdTime=2022-06-23, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=903de30162e2, moduleTitle=AOP Health在2022年欧洲血液学协会年会上公布CONTINUATION-PV研究的最终结果——BESREMi®（罗培根干扰素α-2b）治疗真性红细胞增多症患者长达7.5年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=903de30162e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555473, encodeId=792015554e361, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Lancet Haematol：鲁索替尼治疗真性红细胞增多症的5年随访结果, objectType=article, longId=727794, objectId=0ccae27794b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ccae27794b8, replyNumber=0, likeNumber=95, createdTime=2022-05-26, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ccae27794b8, moduleTitle=Lancet Haematol：鲁索替尼治疗真性红细胞增多症的5年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ccae27794b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555472, encodeId=050f15554e2e0, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症, objectType=article, longId=727286, objectId=b019e27286d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b019e27286d3, replyNumber=0, likeNumber=80, createdTime=2022-05-20, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b019e27286d3, moduleTitle=Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b019e27286d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555471, encodeId=276d15554e1dc, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=AJH：高氧亲和力血红蛋白病相关性红细胞增多症: 41例临床结果和治疗影响, objectType=article, longId=218526, objectId=0d2e21852611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d2e21852611, replyNumber=0, likeNumber=71, createdTime=2021-10-15, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d2e21852611, moduleTitle=AJH：高氧亲和力血红蛋白病相关性红细胞增多症: 41例临床结果和治疗影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d2e21852611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555470, encodeId=6d3815554e042, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=CALR基因突变阳性的红细胞增多症1例, objectType=article, longId=197562, objectId=4bb519e56222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb519e56222, replyNumber=0, likeNumber=87, createdTime=2020-07-17, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb519e56222, moduleTitle=CALR基因突变阳性的红细胞增多症1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bb519e56222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555469, encodeId=032515554694f, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定, objectType=article, longId=196104, objectId=ff9919610447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff9919610447, replyNumber=0, likeNumber=82, createdTime=2020-06-20, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff9919610447, moduleTitle=关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff9919610447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555468, encodeId=b3fb155546806, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Blood：真性红细胞增多症患者白细胞持续升高预示高疾病进展风险, objectType=article, longId=189098, objectId=a96b18909891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a96b18909891, replyNumber=0, likeNumber=91, createdTime=2020-03-03, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a96b18909891, moduleTitle=Blood：真性红细胞增多症患者白细胞持续升高预示高疾病进展风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a96b18909891)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555467, encodeId=bd43155546e63, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！, objectType=article, longId=187425, objectId=b82918e4252e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b82918e4252e, replyNumber=0, likeNumber=73, createdTime=2020-02-06, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b82918e4252e, moduleTitle=Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b82918e4252e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555466, encodeId=bb24155546666, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Blood：JAK2ex13InDel驱动成瘤转化，与慢性嗜酸性粒细胞白血病和真性红细胞增多症有关, objectType=article, longId=185564, objectId=35fa1855647f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35fa1855647f, replyNumber=0, likeNumber=109, createdTime=2020-01-03, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35fa1855647f, moduleTitle=Blood：JAK2ex13InDel驱动成瘤转化，与慢性嗜酸性粒细胞白血病和真性红细胞增多症有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35fa1855647f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555465, encodeId=2116155546523, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Blood：JAK2ex13Del驱动致癌转化，与慢性嗜酸性白血病和真性红细胞增多症相关, objectType=article, longId=181320, objectId=a75718132063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a75718132063, replyNumber=0, likeNumber=0, createdTime=2019-10-17, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a75718132063, moduleTitle=Blood：JAK2ex13Del驱动致癌转化，与慢性嗜酸性白血病和真性红细胞增多症相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a75718132063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555464, encodeId=37031555464ac, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Blood：口服MDM2蛋白拮抗剂Idasanutlin用于真性红细胞增多症的疗效评估, objectType=article, longId=167795, objectId=d99916e79567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d99916e79567, replyNumber=0, likeNumber=77, createdTime=2019-06-08, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d99916e79567, moduleTitle=Blood：口服MDM2蛋白拮抗剂Idasanutlin用于真性红细胞增多症的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d99916e79567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555463, encodeId=fd701555463ed, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=欧盟批准真性红细胞增多症（PV）治疗药物, objectType=article, longId=160820, objectId=cdc91608200a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdc91608200a, replyNumber=0, likeNumber=78, createdTime=2019-02-24, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdc91608200a, moduleTitle=欧盟批准真性红细胞增多症（PV）治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdc91608200a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555462, encodeId=f6c1155546281, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=INT J LAB HEMATOL：利用红细胞和网状细胞参数通过自动血细胞计数筛查遗传性球形红细胞增多症和丙酮酸激酶缺乏症, objectType=article, longId=159372, objectId=58b11593e2a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58b11593e2a8, replyNumber=0, likeNumber=106, createdTime=2019-02-03, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58b11593e2a8, moduleTitle=INT J LAB HEMATOL：利用红细胞和网状细胞参数通过自动血细胞计数筛查遗传性球形红细胞增多症和丙酮酸激酶缺乏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58b11593e2a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555461, encodeId=0a3f1555461f8, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=2018 BSH指南：真性红细胞增多症的诊断和管理, objectType=article, longId=155074, objectId=d0d81550e464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0d81550e464, replyNumber=0, likeNumber=52, createdTime=2018-12-05, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0d81550e464, moduleTitle=2018 BSH指南：真性红细胞增多症的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0d81550e464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555460, encodeId=5bfa15554603a, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=2018 奥地利建议：真性红细胞增多症的管理, objectType=article, longId=145067, objectId=81d214506ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81d214506ed9, replyNumber=0, likeNumber=58, createdTime=2018-07-25, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81d214506ed9, moduleTitle=2018 奥地利建议：真性红细胞增多症的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81d214506ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555459, encodeId=d01d15554592e, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=2018 SIE共识建议：放血疗法治疗真性红细胞增多症, objectType=article, longId=142309, objectId=1c6814230907, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c6814230907, replyNumber=0, likeNumber=70, createdTime=2018-07-04, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c6814230907, moduleTitle=2018 SIE共识建议：放血疗法治疗真性红细胞增多症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c6814230907)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555458, encodeId=c04d155545804, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Blood：在VHL基因内含子中发现神秘外显子，突变可导致红细胞增多症或VHL病, objectType=article, longId=140681, objectId=29a014068128, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29a014068128, replyNumber=0, likeNumber=84, createdTime=2018-06-15, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29a014068128, moduleTitle=Blood：在VHL基因内含子中发现神秘外显子，突变可导致红细胞增多症或VHL病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29a014068128)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555457, encodeId=120e155545efc, content=<a href='/topic/show?id=f016e71581b' target=_blank style='color:#2F92EE;'>#红细胞增多症#</a>, objectTitle=Am J Hematol：羟基脲治疗真红细胞增多症有证据了, objectType=article, longId=124754, objectId=d7e4124e549e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e4124e549e, replyNumber=0, likeNumber=84, createdTime=2017-12-28, rootId=0, userName=linlin2317, userId=4a1014606284, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e4124e549e, moduleTitle=Am J Hematol：羟基脲治疗真红细胞增多症有证据了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e4124e549e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

红细胞增多症

2020-05-29

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Leukemia Res：阿那格雷在真性红细胞增多症中用于血小板定向细胞减少：从大型多中心数据库中洞察实用性和安全性结果

2022-09-12

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

KIDNEY INT：有“高原红细胞增多症”的藏族居民，他们的肾脏临床病理特征表现如何？

2022-06-25

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

AOP Health在2022年欧洲血液学协会年会上公布CONTINUATION-PV研究的最终结果——BESREMi®（罗培根干扰素α-2b）治疗真性红细胞增多症患者长达7.5年

2022-06-23

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Lancet Haematol：鲁索替尼治疗真性红细胞增多症的5年随访结果

2022-05-26

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Blood：羟基脲 vs 聚乙二醇化IFN-α 治疗原发性血小板增多症/真性红细胞增多症

2022-05-20

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

AJH：高氧亲和力血红蛋白病相关性红细胞增多症: 41例临床结果和治疗影响

2021-10-15

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

CALR基因突变阳性的红细胞增多症1例

2020-07-17

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定

2020-06-20

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Blood：真性红细胞增多症患者白细胞持续升高预示高疾病进展风险

2020-03-03

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！

2020-02-06

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Blood：JAK2ex13InDel驱动成瘤转化，与慢性嗜酸性粒细胞白血病和真性红细胞增多症有关

2020-01-03

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Blood：JAK2ex13Del驱动致癌转化，与慢性嗜酸性白血病和真性红细胞增多症相关

2019-10-17

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Blood：口服MDM2蛋白拮抗剂Idasanutlin用于真性红细胞增多症的疗效评估

2019-06-08

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

欧盟批准真性红细胞增多症（PV）治疗药物

2019-02-24

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

INT J LAB HEMATOL：利用红细胞和网状细胞参数通过自动血细胞计数筛查遗传性球形红细胞增多症和丙酮酸激酶缺乏症

2019-02-03

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

2018 BSH指南：真性红细胞增多症的诊断和管理

2018-12-05

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

2018 奥地利建议：真性红细胞增多症的管理

2018-07-25

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

2018 SIE共识建议：放血疗法治疗真性红细胞增多症

2018-07-04

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Blood：在VHL基因内含子中发现神秘外显子，突变可导致红细胞增多症或VHL病

2018-06-15

linlin2317 (审核中...)

前往app查看评论内容

#红细胞增多症#

Am J Hematol：羟基脲治疗真红细胞增多症有证据了

2017-12-28

科室
- - 订阅+
  - 更多科室
工具
服务